Back to News
Market Impact: 0.3
IDEXX Sales Rise 10% as Margin Outlook Slips: Rapid Earnings Reaction
Source: fool.com
Corporate EarningsCorporate Guidance & OutlookHealthcare & BiotechCompany Fundamentals
IDEXX reported third-quarter revenue growth of 10% to about $1.21 billion, with recurring diagnostics sales to veterinarians up 11%. The article says the higher 2026 profit forecast is not driven by testing demand but does not specify the forecast increase or its drivers.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
More News
- Marvell to buy Lumentum in $115 billion deal in AI data-center bet
- Marvell, Lumentum tout historic $115B deal to create ‘category leader' in AI connectivity
- Palantir reports booming U.S. commercial revenue growth, topping government for first time
- Anthropic releases amended IPO prospectus with third-quarter financials
- Coinbase has been battered over the past month. Morgan Stanley says steer clear
- The AI boom is facing another supply crunch. This time it’s the amount of capital available to feed Silicon Valley’s endless need for cash
From AllMind Research
- AllMind Platform Feature Updates - Fall 2026
- AI Credit Covenant Monitoring: From Clause to Review
- AI-Led Expert Interviews vs. Transcript Libraries
- How to Evaluate AI Report Writers for Financial Analysis
- Augmented Intelligence: AllMind, Elevate Human Judgement With an Accessible, Powerful, Data-Driven Financial AI Toolkit